ZA965499B - Use of Stat 5 SH2 domain specific compounds to enhance erythropoiesis. - Google Patents

Use of Stat 5 SH2 domain specific compounds to enhance erythropoiesis.

Info

Publication number
ZA965499B
ZA965499B ZA9605499A ZA965499A ZA965499B ZA 965499 B ZA965499 B ZA 965499B ZA 9605499 A ZA9605499 A ZA 9605499A ZA 965499 A ZA965499 A ZA 965499A ZA 965499 B ZA965499 B ZA 965499B
Authority
ZA
South Africa
Prior art keywords
stat
specific compounds
domain specific
enhance erythropoiesis
erythropoiesis
Prior art date
Application number
ZA9605499A
Inventor
Damien John Dunnington
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA965499B publication Critical patent/ZA965499B/en

Links

ZA9605499A 1995-06-30 1996-06-28 Use of Stat 5 SH2 domain specific compounds to enhance erythropoiesis. ZA965499B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49735795A 1995-06-30 1995-06-30

Publications (1)

Publication Number Publication Date
ZA965499B true ZA965499B (en) 1998-03-30

Family

ID=27663409

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA9605500A ZA965500B (en) 1995-06-30 1996-06-28 Use of Stat 6 SH2 domain specific compounds to treat allergic reactions.
ZA9605499A ZA965499B (en) 1995-06-30 1996-06-28 Use of Stat 5 SH2 domain specific compounds to enhance erythropoiesis.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA9605500A ZA965500B (en) 1995-06-30 1996-06-28 Use of Stat 6 SH2 domain specific compounds to treat allergic reactions.

Country Status (1)

Country Link
ZA (2) ZA965500B (en)

Also Published As

Publication number Publication date
ZA965500B (en) 1998-03-30

Similar Documents

Publication Publication Date Title
EP0871444A4 (en) 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
AU629465B2 (en) Bleaching compounds and compositions
PL324992A1 (en) Novel derivatives of 2,3-dioxotetrahydoquinoxaline
AU3284395A (en) Synthesis of 1,1,1,3,3,-pentafluoropropane
AU4329396A (en) Use of 3,4-diphenylchromans
EP0683676A4 (en) Directed biodistribution of small molecules.
IL113248A0 (en) Use of alpha - 1c specific compounds
GB9508791D0 (en) Compositions of matter
ZA964010B (en) Use of pyrrole compounds as antifouling agents.
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
EP0871436A4 (en) USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS
GB9405229D0 (en) Compositions of matter
EP0835104A4 (en) Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis
GB9507297D0 (en) New composition of matter
AU4440596A (en) Use of hcp SH2 specific compounds to enhance erythropoiesis
GB9409944D0 (en) New compositions of matter
PL310675A1 (en) Application of ferrocene
ZA965499B (en) Use of Stat 5 SH2 domain specific compounds to enhance erythropoiesis.
HUP9603028A3 (en) Use of aquous solution of l-triptophane-and/or l-threonine-salts
IL119744A0 (en) Use of 8,9-dehydroestrone
AU4292496A (en) Improved mutable composition
CA2120874A1 (en) Form of Form 1 Ranitidine
ZA963825B (en) Composition of matter
ZA961000B (en) Use of HCP specific compounds to enhance erythropoiesis
GB9308077D0 (en) Assay of 2,4-dinitrophenylhydrazones and related compounds